CD83 and breast carcinoma: Iwamoto et al. demonstrated that the infiltration of breast cancer by CD83+ DCs is an independent immunologic prognostic parameter, as the number of intratumoural CD83+ DCs was inversely correlated with lymph node metastasis and significantly associated with longer relapse-free and overall survival.